AHS Cancer Control Alberta: Prostatic Neoplasms trials

The registry lists 20 Prostatic Neoplasms studies with AHS Cancer Control Alberta as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 7No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Radiation Treatment of the Prostate That is Specially Adjusted for Each PersonRecruitingNCT07578519Phase 2
• PSMA-PET Directed Radiation Therapy for High-Risk Prostate CancerNot yet recruitingNCT07291557Phase 2
• A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate CancerTerminatedNCT05712174Phase 2
• PSMA-PET/CT RegistryTerminatedNCT05709535
• Participating in Tai Chi to Reduce Anxiety and Keep up Physical FunctionActive, not recruitingNCT05452824Not applicable
• A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate GlandCompletedNCT02004418Phase 1/2
• Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateTerminatedNCT01996696Phase 2
• A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed ImplantStatus unknownNCT01437085
• Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric ConsequencesStatus unknownNCT01355185
• Magnetic Resonance (MR) Spectroscopy in Localized Prostate CancerCompletedNCT00756392Not applicable
• Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and BiomarkersCompletedNCT00676286Phase 1
• Blood Test to Measure DNA Damage in BloodTerminatedNCT00523471
• Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate CancerCompletedNCT00310479Not applicable
• A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate CancerCompletedNCT00271687Phase 2
• Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant TherapyCompletedNCT00127816Not applicable
• High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy ImplantationCompletedNCT00126854Not applicable
• Mathematical Modeling Analysis of Serum Prostate Specific Antigen After RadiotherapyCompletedNCT00126815
• The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate CancerStatus unknownNCT00126802Phase 1/2
• Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal ManipulationCompletedNCT00124410
• Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate CancerTerminatedNCT00122265